Predictions
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€38.00
09.01.23
09.01.23
-
09.01.24
09.01.24
-1.05%
21.01.23
21.01.23
Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€34.35
22.12.22
22.12.22
-
22.12.23
22.12.23
13.25%
24.08.23
24.08.23
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
13.11.22
13.11.22
€3.00
13.11.23
13.11.23
-0.60%
26.11.22
26.11.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
B.R.A.I.N. Biotechnology Research and Information Network AG
Start price
Target price
Perf. (%)
€4.98
13.10.22
13.10.22
-
13.10.23
13.10.23
-18.27%
14.10.23
14.10.23
Stratec SE
Start price
Target price
Perf. (%)
€85.00
26.07.22
26.07.22
€66.00
26.07.23
26.07.23
4.94%
06.08.22
06.08.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€49.15
01.06.22
01.06.22
-
01.06.23
01.06.23
-2.34%
11.06.22
11.06.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€42.25
01.06.22
01.06.22
-
01.06.23
01.06.23
-0.47%
11.06.22
11.06.22
Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Vita 34 AG
Start price
Target price
Perf. (%)
€11.05
18.05.22
18.05.22
-
18.05.23
18.05.23
-0.45%
28.05.22
28.05.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Biofrontera AG
Start price
Target price
Perf. (%)
€1.16
18.05.22
18.05.22
-
18.05.23
18.05.23
2.59%
28.05.22
28.05.22
Could be very worthwhile Investment >20% year
Undervalued
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€41.80
12.05.22
12.05.22
-
12.05.23
12.05.23
-6.22%
13.05.23
13.05.23
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€48.92
25.04.22
25.04.22
€120.00
03.02.25
03.02.25
-8.85%
30.08.24
30.08.24
Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Affimed N.V.
Start price
Target price
Perf. (%)
€4.75
11.04.22
11.04.22
-
11.04.23
11.04.23
-41.07%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
07.03.22
07.03.22
-
07.03.23
07.03.23
0.60%
19.03.22
19.03.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Affimed N.V.
Start price
Target price
Perf. (%)
€4.14
26.02.22
26.02.22
-
26.02.23
26.02.23
-59.29%
27.10.22
27.10.22
Could be very worthwhile Investment >20% year
Medigene AG
Start price
Target price
Perf. (%)
€3.79
22.02.22
22.02.22
€4.00
22.02.23
22.02.23
-45.05%
23.02.23
23.02.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€3.71
22.02.22
22.02.22
€5.00
22.02.23
22.02.23
18.89%
23.02.22
23.02.22
Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation